{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:43:17Z","timestamp":1768466597468,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.leukres.2009.06.005","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T08:18:19Z","timestamp":1246868299000},"page":"307-311","source":"Crossref","is-referenced-by-count":11,"title":["Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Abdulmunem M.","family":"Abulayha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah A.","family":"Tabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman I.","family":"Shawesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Elbasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrhman S.","family":"Elbanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra M.","family":"Lamami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Bredan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.06.005_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.005_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/sonc.2002.30145","article-title":"Rituximab: ongoing and future clinical development","volume":"29","author":"Grillo-Lopez","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.leukres.2009.06.005_bib3","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood.V95.10.3052","article-title":"Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma","volume":"95","author":"Hainsworth","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.005_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.2005.12.052","article-title":"Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.06.005_bib5","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.06.005_bib6","first-page":"611","article-title":"Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression","volume":"5","author":"Davis","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2009.06.005_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008416911099","article-title":"Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma","volume":"9","author":"Berinstein","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2009.06.005_bib8","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2002-06-1639","article-title":"Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance","volume":"101","author":"Manshouri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.005_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/j.1460-2075.1988.tb02867.x","article-title":"Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains","volume":"7","author":"Einfeld","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2009.06.005_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1073\/pnas.85.1.208","article-title":"Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes","volume":"85","author":"Tedder","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2009.06.005_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.005_bib12","first-page":"1763","article-title":"Clinical status and optimal use of rituximab for B-cell lymphomas","volume":"12","author":"McLaughlin","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.leukres.2009.06.005_bib13","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.06.005_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2006.09.004","article-title":"Pharmacokinetics of rituximab and its clinical use: thought for the best use?","volume":"62","author":"Cartron","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.leukres.2009.06.005_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.leukres.2009.06.005_bib16","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/art.20592","article-title":"Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus","volume":"50","author":"Anolik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.leukres.2009.06.005_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cyto.10125","article-title":"Improved flow cytometric method to enumerate residual cells: minimal linear detection limits for platelets, erythrocytes, and leukocytes","volume":"50","author":"Pichler","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.leukres.2009.06.005_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1471-4906(03)00119-4","article-title":"Transitional B cells: step by step towards immune competence","volume":"24","author":"Chung","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.leukres.2009.06.005_bib19","first-page":"4","article-title":"The paths and molecular controls of peripheral B-cell development","author":"Liu","year":"1996","journal-title":"Immunologist"},{"key":"10.1016\/j.leukres.2009.06.005_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"Klein","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2009.06.005_bib21","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.188.9.1691","article-title":"Identification of functional human splenic memory B cells by expression of CD148 and CD27","volume":"188","author":"Tangye","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2009.06.005_bib22","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.leukres.2009.06.005_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.183.1.77","article-title":"CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype","volume":"183","author":"Galibert","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2009.06.005_bib24","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.4049\/jimmunol.166.9.5567","article-title":"CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains\/rafts-mediated signaling system","volume":"166","author":"Suzuki","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2009.06.005_bib25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/art.22603","article-title":"BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjogren's syndrome","volume":"56","author":"Pers","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.leukres.2009.06.005_bib26","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1002\/art.22810","article-title":"Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy","volume":"56","author":"Anolik","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T07:57:54Z","timestamp":1589961474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0145212609002823"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.06.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}